HL and Primary Malignancies
The risk, localisation and timing of third malignancies in 3,122 five-year survivors of Hodgkin lymphoma were assessed. Patients in this cohort were diagnosed before age 51 years and received treatment between 1965 and 1995.
Following a median follow-up of 22.6 years, 832 patients had developed a second malignancy and 126 patients a third one. Among female patients, the 10-year cumulative incidence of a third malignancy was 17.1%; among male patients it was 9.2%. Patients with a second malignancy were at a higher risk of developing another malignancy. For more information, click here to read the full article.